BioCentury
ARTICLE | Company News

Teva, Proneuron glatiramer deal

December 4, 2001 8:00 AM UTC

TEVA and Proneuron (Ness-Ziona, Israel) partnered to develop glatiramer to treat multiple acute and chronic neurological diseases. TEVA will fund preclinical and clinical development and will pay Pron...